Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yunkeping is a Traditional Chinese Medicine (TCM) product developed and manufactured by Nantong Jidesheng Pharmaceutical. It is available in granule and syrup formulations and is primarily indicated for the treatment of vertigo, dizziness, and symptoms associated with hypertension, such as headache and tinnitus. The formulation is based on traditional principles to calm the liver, extinguish wind, clear heat, and promote blood circulation. It is a multi-herb combination typically including *Gastrodia elata*, *Uncaria rhynchophylla*, and *Scutellaria baicalensis*. The product is approved in China for clinical use in managing dizziness related to liver-yang hyperactivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yunkeping.